TP53 and Familial prostate cancer: PEITC induced a significant reduction in the expression levels of p53R175H and p53R248W mutants in LAPC-4 and VCaP cells, respectively, demonstrating that it affects the stability of different “hotspot” p53 mutants, with varied potency, in prostate cancer cells (Fig. 1e).